[PP.20.05] THE EFFECT OF PROSTAGLANDIN E1 ANALOGUE TREATMENT ON MORTALITY AND AMPUTATION RATE IN PATIENTS WITH CRITICAL LIMB ISCHEMIA

2017 ◽  
Vol 35 ◽  
pp. e251
Author(s):  
L. Gaspar ◽  
A. Komornikova ◽  
V. Stvrtinova ◽  
P. Gavornik ◽  
E. Ambrozy ◽  
...  
Keyword(s):  
Critical Limb Ischemia ◽  
Prostaglandin E1 ◽  
Limb Ischemia ◽  
Amputation Rate

Prostaglandin E1 Improves Endothelial Function in Critical Limb Ischemia

2003 ◽  
Vol 41 (2) ◽  
pp. 249-253 ◽  
Author(s):  
Simona Marchesi ◽  
Leonella Pasqualini ◽  
Rita Lombardini ◽  
Gaetano Vaudo ◽  
Graziana Lupattelli ◽  
...  
Keyword(s):  
Endothelial Function ◽  
Critical Limb Ischemia ◽  
Prostaglandin E1 ◽  
Limb Ischemia

Prostaglandin E1 in critical limb ischemia transcutaneous PO2: A predictor of efficacy?

2011 ◽  
Vol 3 (01) ◽  
pp. 97-99 ◽  
Author(s):  
Thomas Weiss ◽  
Joachim Griesshaber ◽  
Waltraud Rogatti ◽  
Claudia Wilhelm ◽  
Curt Diehm ◽  
...  
Keyword(s):  
Critical Limb Ischemia ◽  
Prostaglandin E1 ◽  
Limb Ischemia ◽  
Transcutaneous Po2

scholarly journals Noninvasive management of the diabetic foot with critical limb ischemia: current options and future perspectives

2011 ◽  
Vol 2 (6) ◽  
pp. 247-255 ◽  
Author(s):  
Mathias Weck ◽  
Torsten Slesaczeck ◽  
Hannes Rietzsch ◽  
Dirk Münch ◽  
Thomas Nanning ◽  
...  
Keyword(s):  
Peripheral Arterial Disease ◽  
Critical Limb Ischemia ◽  
Diabetic Foot ◽  
Local Treatment ◽  
Limb Ischemia ◽  
Arterial Disease ◽  
Arterial Stenosis ◽  
Amputation Rate ◽  
Foot Ulcers ◽  
Peripheral Arterial

Foot ulcers are a major complication in patients with diabetes mellitus and involve dramatic restrictions to quality of life and also lead to enormous socio-economical loss due to the high amputation rate. The poor and slow wound healing is often aggravated by the frequent comorbidity of foot ulcers with peripheral arterial disease, making the treatment of this condition even more complicated. While the local treatment of foot ulcers is mainly based on mechanical relief and prevention or treatment of infection, improving perfusion of the impaired tissue remains the major challenge in peripheral arterial disease. While focal arterial stenosis is the domain of interventional angioplasty or vascular surgery, patients with critical limb ischemia and lacking options for revascularization have a much worse prognosis, because current treatment options avoiding amputation are scarce. However, based on recent research efforts, there is rising hope for promising and more-effective therapeutic approaches for these patients. Here, we discuss the current improvements of established therapies aimed at an improvement of limb perfusion, as well as the development of novel cutting-edge therapies based on stem-cell technology. The experiences of a ‘high-volume center’ for treatment of diabetic foot syndrome with a current major amputation rate of 4% are discussed.

Sirolimus-eluting Versus Bare Stents After Suboptimal Infrapopliteal Angioplasty for Critical Limb Ischemia: Enduring 1-year Angiographic and Clinical Benefit

2007 ◽  
Vol 14 (2) ◽  
pp. 241-250 ◽  
Author(s):  
Dimitris Siablis ◽  
Dimitris Karnabatidis ◽  
Konstantinos Katsanos ◽  
George C. Kagadis ◽  
Pantelis Kraniotis ◽  
...  
Keyword(s):  
Critical Limb Ischemia ◽  
Clinical Benefit ◽  
Limb Ischemia ◽  
Infrapopliteal Angioplasty
Sign in / Sign up

Export Citation Format

Share Document